Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06204185Completed
Randomised, double-blind trial of metformin 1% gel in periodontitis (2 arms), sponsored by Ain Shams University. Primary endpoints: Receptor Activator of Nuclear Factor Kappa-B Ligand at 1 month and Osteoprotegrin at 1 month. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06204185.